An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration datesort ascending
Recorded Presentations from the NCCN 2023 Annual Congress: Hematologic Malignancies™ 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Revolutionizing Hematologic Cancer Treatment: The Promise of Bispecific T-Cell Engagers 1.00 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Navigating the Challenges: Effective Management of Toxicities in CAR T-Cell Therapies 1.00 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Adult Acute Lymphocytic Leukemia: Strategies for Selection of Consolidation Therapy 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Acute Myeloid Leukemia: Selecting Induction Therapy Based on Biological Disease Factors 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Case Studies in the Management of Leukemia 0.75 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Navigating Change: Best Practices for Integrating WHO/ICC Classification Systems in the Management of Hematologic Malignancies 1.00 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Management of Newly Diagnosed Multiple Myeloma Based on Risk Stratification 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Incorporating Immunotherapeutic Strategies in the Management of Relapsed/Refractory Multiple Myeloma 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Tackling Inequities in Multiple Myeloma: Practical Steps for Improving Access and Quality of Care 1.00 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Advances in the Management of Classical Hodgkin Lymphoma 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Perioperative Management of Anticoagulation and Antithrombotic Therapy 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Updates in the Management of Mantle Cell Lymphoma: Is There Still a Role for Transplant? 1.00 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Relapsed/Refractory CLL/SLL: Overcoming Resistance to Covalent BTKi and/or BCL2 Inhibitors 0.50 12/01/2023 - 12:00am to 12/01/2024 - 12:00am
Management of Toxicities of BTK Inhibitors in B-Cell Malignancies 0.75 12/01/2023 - 12:00am to 12/01/2024 - 12:00am

Pages